Infant Botulism, Israel, 2007-2021

Emerg Infect Dis. 2023 Feb;29(2):235-241. doi: 10.3201/eid2902.220991.

Abstract

Infant botulism (IB) is an intestinal toxemia that manifests as descending paralysis, constipation, and, in some cases, respiratory failure. Laboratory-confirmed IB cases are rare, and recent data in Israel are lacking. We conducted a national multicenter retrospective study of laboratory-confirmed IB cases reported in Israel during 2007-2021. A total of 8 cases were reported during the study period. During 2019-2021, incidence may have increased because of a cluster of 5 cases. Infant median age for diagnosis was 6.5 months, older than previously reported (3 months). Most cases occurred during March-July. Honey consumption was reported in 1 case, and possible environmental risk factors (living nearby rural or construction areas, dust exposure, and having a father who works as a farmer) were reported in 6 cases. Although IB is rare, its incidence in Israel may have increased over recent years, and its epidemiology and risk factors differ from cases reported previously in Israel.

Keywords: Clostridium botulinum; Israel; bacteria; botulism neurotoxin; epidemiology; food safety; foodborne diseases; honey; infant botulism; pediatrics.

Publication types

  • Review

MeSH terms

  • Botulism* / diagnosis
  • Botulism* / epidemiology
  • Botulism* / etiology
  • Clostridium botulinum*
  • Humans
  • Incidence
  • Infant
  • Israel / epidemiology
  • Multicenter Studies as Topic
  • Retrospective Studies